Skip to main content
SpringerLink
Log in

Presence of risk factors does not affect outcome in early stage pediatric Hodgkin lymphoma treated with ABVD

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mauz-Körholz C, Metzger ML, Kelly KM, Schwartz CL, Castellanos ME, Dieckmann K et al (2015) Pediatric Hodgkin lymphoma. J Clin Oncol Off J Am Soc Clin Oncol 33(27):2975–2985

    Article  Google Scholar 

  2. Schwartz CL, Constine LS, Villaluna D, London WB, Hutchison RE, Sposto R et al (2009) A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425. Blood 114(10):2051–2059

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Donaldson SS, Link MP, Weinstein HJ, Rai SN, Brain S, Billett AL et al (2007) Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin’s disease. J Clin Oncol Off J Am Soc Clin Oncol 25(3):332–337

    Article  CAS  Google Scholar 

  4. Wolden SL, Chen L, Kelly KM, Herzog P, Gilchrist GS, Thomson J et al (2012) Long-term results of CCG 5942: a randomized comparison of chemotherapy with and without radiotherapy for children with Hodgkin’s lymphoma—a report from the Children’s Oncology Group. J Clin Oncol Off J Am Soc Clin Oncol 30(26):3174–3180

    Article  Google Scholar 

  5. Nachman JB, Sposto R, Herzog P, Gilchrist GS, Wolden SL, Thomson J et al (2002) Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin’s disease who achieve a complete response to chemotherapy. J Clin Oncol Off J Am Soc Clin Oncol 20(18):3765–3771

    Article  Google Scholar 

  6. Tebbi CK, Mendenhall NP, London WB, Williams JL, Hutchison RE, Fitzgerald TJ et al (2012) Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: a report from the Children’s Oncology Group. Pediatr Blood Cancer 59(7):1259–1265

    Article  PubMed  PubMed Central  Google Scholar 

  7. Mauz-Körholz C, Hasenclever D, Dörffel W, Ruschke K, Pelz T, Voigt A et al (2010) Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin’s lymphoma: the GPOH-HD-2002 study. J Clin Oncol Off J Am Soc Clin Oncol 28(23):3680–3686

    Article  Google Scholar 

  8. Oberlin O, Leverger G, Pacquement H, Raquin MA, Chompret A, Habrand JL et al (1992 Oct) Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin’s disease: the experience of the French Society of Pediatric Oncology. J Clin Oncol Off J Am Soc Clin Oncol 10(10):1602–1608

    CAS  Google Scholar 

  9. Vecchi V, Pileri S, Burnelli R, Bontempi N, Comelli A, Testi AM et al (1993) Treatment of pediatric Hodgkin disease tailored to stage, mediastinal mass, and age. An Italian (AIEOP) multicenter study on 215 patients. Cancer 72(6):2049–2057

    Article  CAS  PubMed  Google Scholar 

  10. Dieckmann K, Pötter R, Hofmann J, Heinzl H, Wagner W, Schellong G et al (2003) Does bulky disease at diagnosis influence outcome in childhood Hodgkin’s disease and require higher radiation doses? Results from the German-Austrian pediatric multicenter trial DAL-HD-90. Int J Radiat Oncol Biol Phys 56(3):644–652

    Article  PubMed  Google Scholar 

  11. Bonadonna G, Santoro A (1982 Mar) ABVD chemotherapy in the treatment of Hodgkin’s disease. Cancer Treat Rev 9(1):21–35

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medical Oncology, Dr. BRA IRCH, All India Institute of Medical Sciences, New Delhi, 110 029, India

    Sainath Bhethanabhotla & Sameer Bakhshi

Authors
  1. Sainath Bhethanabhotla
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sameer Bakhshi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sameer Bakhshi.

Ethics declarations

Fundings

None.

Conflict of interest

The authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bhethanabhotla, S., Bakhshi, S. Presence of risk factors does not affect outcome in early stage pediatric Hodgkin lymphoma treated with ABVD. Ann Hematol 96, 521–522 (2017). https://doi.org/10.1007/s00277-016-2880-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-016-2880-y

Keywords

Search

Navigation